½ÃÀ庸°í¼­
»óǰÄÚµå
1602395

¼¼°èÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå : ¸ÞÄ¿´ÏÁòº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)

Acute Care Needleless Connectors Market by Mechanism (Negative Fluid Displacement, Neutral Fluid Displacement, Positive Fluid Displacement), End User (Clinics & Ambulatory Settings, Hospitals) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 6¾ï 2,347¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 6¾ï 6,655¸¸ ´Þ·¯·Î·Î ÃßÁ¤µÇ¸ç, CAGR 7.32%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 10¾ï 2,257¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀº Ä«Å×ÅÍ, ¸µ°Å ¶óÀÎ ¹× ±âŸ ±â±¸¸¦ ¹Ù´Ã ¾øÀÌ ¿¬°áÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±â¿¡ ÃÊÁ¡À» ¸ÂÃ߸ç ÁÖ·Î ¹Ù´Ã »óÇØ ºÎ»ó À§ÇèÀ» ÁÙÀ̰í, ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇØ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ Ä¿³ØÅÍ´Â º´¿ø, Ŭ¸®´Ð, Àå±â °ü¸® ½Ã¼³¿¡¼­ °¨¿°À» ¿¹¹æÇϰí ÇコÄɾî Àü¹ÝÀÇ È¿À²¼ºÀ» Çâ»ó½Ã۴µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ÀÔ¿ø Áõ°¡¸¦ ÇÊ¿ä·Î ÇÏ´Â ¸¸¼ºÁúȯ À¯º´·ü »ó½Â, °íµµÀÇ ÇコÄɾî ÀýÂ÷ äÅà Áõ°¡, ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ÃËÁøÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ÀÇ Àǹ«È­ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÇコÄÉ¾î °ü·Ã °¨¿°(HAI)¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶°¡, È¿°úÀûÀÎ ´Ïµé¸®½º Ä¿³ØÅÍÀÇ Çʿ伺À» °­Á¶ÇØ, ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ±×·¯³ª °íµµÀÇ Ä¿³ØÅÍ¿Í °ü·ÃµÈ °íºñ¿ëÀ̳ª ºÎÀûÀýÇÑ »ç¿ë¿¡ ÀÇÇÑ ¿À¿°À¸·Î À̾îÁö´Â ÀáÀçÀûÀÎ ¸®½ºÅ© µîÀÇ Á¦¾àÀÌ ½ÃÀå ¼ºÀåÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ Ç×±Õ ±â¼úÀ̳ª ¿ø°Ý ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ½º¸¶Æ® Ä¿³ØÅ͸¦ ÅëÇÑ ºñ¿ë È¿À²¼º°ú ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÁßÁ¡À» µÐ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ¿© ȯÀÚ Ä£È­ÀûÀ̰í È¿À²ÀûÀÏ »Ó¸¸ ¾Æ´Ï¶ó Æø³ÐÀº ÇコÄÉ¾î ½Ã½ºÅÛ¿¡ ÀûÇÕÇÑ Ä¿³ØÅ͸¦ °³¹ßÇØ¾ß ÇÕ´Ï´Ù. µð½ºÆ÷ÀúºíÀÇ µµÀÔÀº °¨¿° Á¦¾î¸¦ °­È­ÇÏ°í ½ÃÀå È®´ëÀÇ ¶Ç ´Ù¸¥ ¼ö´ÜÀÌ µË´Ï´Ù. ½ÃÀå Á¡À¯À²À» ÃÖÀûÈ­ÇÏ´Â Áß¿äÇÑ ¹æ¹ý Áß Çϳª´Â °ø±Þ¸Á°ú À¯Åë¸ÁÀ» °³¼±ÇÏ°í Æ¯È÷ ½ÅÈï ½ÃÀå¿¡¼­ ´Ù¾çÇÑ Áö¿ª¿¡¼­ Á¦Ç°À» ¾òÀ» ¼ö ÀÖµµ·Ï ÇÏ´Â Á¦ÈÞ ¹× Çù·Â °ü°èÀÔ´Ï´Ù. ±×·¯³ª ±ÔÁ¦ º¯È­¸¦ Áö¼ÓÀûÀ¸·Î ÆÄ¾ÇÇÏ°í °Ç°­ °ü¸® Á¾»çÀÚ ±³À°¿¡ ÅõÀÚÇÏ´Â °ÍÀÌ ÀÌ·¯ÇÑ Àå¾Ö¹°À» ±Øº¹ÇϱâÀ§ÇÑ Àü·«À¸·Î ±ÇÀåµË´Ï´Ù. ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ °æÀïÀº ¿©ÀüÈ÷ ¿Ï¸¸Çϸç, ¼ÒÀç¿Í »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º ¼³°èÀÇ Çõ½Å ±âȸ°¡ ÇâÈÄ ¼ºÀå ±Ëµµ¸¦ Á¿ìÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÃÖÁ¾ÀûÀ¸·Î´Â ȯÀÚÀÇ ¿ä±¸¿Í ±ÔÁ¦ÀÇ Æ²À» ÀÌÇØÇÏ´Â °ÍÀÌ ÀÌ °è¼Ó ÁøÈ­ÇÏ´Â ÇコÄÉ¾î ¿µ¿ª¿¡¼­ Å« Áøº¸ÀÇ ±æÀ» ¿­¾î ºñÁî´Ï½ºÀÇ º¸±ÞÀ» È®´ë½Ãų °ÍÀ¸·Î »ý°¢µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 6¾ï 2,347¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 6¾ï 6,655¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 10¾ï 2,257¸¸ ´Þ·¯
CAGR(%) 7.32%

½ÃÀå ¿ªÇÐ : ±Þ¼ºÀåÇÏ´Â ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¹Ù´Ã »óÇØ ºÎ»óÀ¸·Î ÀÎÇÑ °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â °Í¿¡ ´ëÇÑ °ü½É Áõ°¡
    • ¸¸¼ºÁúȯÀÇ À¯Çà°ú Á¤¸Æ³» Ä¡·áÀÇ Ã³¹æ Áõ°¡
    • »ç¿ëÀÇ ¿ëÀ̼º°ú Æí¸®¼º¿¡ ÀÇÇÑ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ Ã¤¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ¿Í °ü·ÃµÈ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ ¼ÒÀç¿Í ¼º´É¿¡ À־ÀÇ ²÷ÀÓ¾ø´Â Çõ½Å
    • »õ·Î¿î ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ µµÀÔ
  • ½ÃÀåÀÇ °úÁ¦
    • ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ ÀåÁ¡°ú »ç¿ë¹ý¿¡ °üÇÑ ³·Àº ÀÎÁöµµ

Porter's Five Forces : ±Þ¼º±â ÀÇ·á¿ë ¹Ù´Ã¾ø´Â Ä¿³ØÅÍ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±Þ¼º±â ÀÇ·á ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÞÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¹Ù´Ã »óÇØ ºÎ»ó »ç°í¿¡ ÀÇÇÑ °¨¿° Æ®·£½º¹Ì¼ÇÀÇ ÃÖ¼ÒÈ­¿¡ ´ëÇÑ ÁÖ¸ñ °íÁ¶
      • ¸¸¼ºÁúȯÀÇ ¸¸¿¬°ú Á¡Àû¿ä¹ýÀÇ Ã³¹æ Áõ°¡
      • »ç¿ëÀÇ ¿ëÀ̼º°ú Æí¸®¼ºÀ¸·ÎºÎÅÍ, ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ Ã¤¿ë
    • ¾ïÁ¦¿äÀÎ
      • ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ¿Í °ü·ÃµÈ °íºñ¿ë
    • ±âȸ
      • ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ ¼ÒÀç¿Í ¼º´ÉÀÇ Áö¼ÓÀûÀÎ Çõ½Å
      • »õ·Î¿î ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ µµÀÔ
    • °úÁ¦
      • ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ ÀåÁ¡°ú »ç¿ë¹ý¿¡ °üÇÑ ÇÑÁ¤µÈ ÀνÄ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå : ±â±¸º°

  • ºÎÀÇ À¯Ã¼ º¯À§
  • Áß¼º À¯Ã¼ ġȯ
  • Æ÷ÁöƼºê À¯Ã¼ ġȯ¹ý

Á¦7Àå ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ŭ¸®´Ð°ú ¿Ü·¡ Áø·á¼Ò
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • AdvaCare Pharma
  • Amsino International, Inc.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton Dickinson and Company
  • Cardinal Health, Inc.
  • ICU Medical, Inc.
  • JCM-MED
  • MEDEREN
  • Medline Industries, LP.
  • Merit Medical Systems, Inc.
  • Narang Medical Limited
  • Nexus Medical
  • Polymedicur
  • Romsons Group of Industries
  • Surgmed Group
  • Teleflex Incorporated
  • Vygon SAS
AJY 24.12.10

The Acute Care Needleless Connectors Market was valued at USD 623.47 million in 2023, expected to reach USD 666.55 million in 2024, and is projected to grow at a CAGR of 7.32%, to USD 1,022.57 million by 2030.

The acute care needleless connectors market focuses on medical devices used to connect catheters, IV lines, and other apparatus without using needles, primarily to reduce the risk of needle-stick injuries and enhance patient safety. These connectors are essential in hospitals, clinics, and long-term care facilities to prevent infections and improve overall healthcare efficiency. The key factors driving the growth of this market include the rising prevalence of chronic diseases necessitating increased hospital admissions, the growing adoption of advanced healthcare procedures, and stringent regulatory mandates promoting patient safety. Additionally, increasing awareness about healthcare-associated infections (HAIs) underscores the necessity for effective needleless connectors, further bolstering demand. However, limitations such as high costs associated with advanced connectors and potential risks of improper use leading to contamination challenge market growth. Continuous innovation, focusing on cost-efficiency and improved patient outcomes, particularly through antimicrobial technology and smart connectors that allow remote monitoring, offers lucrative opportunities. Companies should invest in R&D to develop connectors that are not only patient-friendly and efficient but also compatible with a wide range of healthcare systems. The introduction of disposables enhances infection control, making it another avenue for market expansion. One critical way to optimize market share is through partnerships and collaborations aimed at improving supply chains and distribution networks, ensuring product availability across diverse regions, especially in emerging markets. However, staying abreast of regulatory changes and investing in training for healthcare workers are recommended strategies to overcome these hurdles. The acute care needleless connectors market remains moderately competitive, with opportunities for innovations in materials and user-interface designs likely to dictate future growth trajectories. Ultimately, understanding patient needs and regulatory frameworks will pave the way for significant advancements and escalate business proliferation in this ever-evolving healthcare domain.

KEY MARKET STATISTICS
Base Year [2023] USD 623.47 million
Estimated Year [2024] USD 666.55 million
Forecast Year [2030] USD 1,022.57 million
CAGR (%) 7.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute Care Needleless Connectors Market

The Acute Care Needleless Connectors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing focus on minimizing the risk of infection transmission through needlestick injuries
    • Prevalence of chronic diseases and rise in prescription of intravenous therapy
    • Adoption of acute-care-needleless-connectors owing to ease of use and convenience
  • Market Restraints
    • High costs associated with acute care needleless connectors
  • Market Opportunities
    • Continuous innovations in materials and performance of acute care needleless connectors
    • Introduction of novel acute care needleless connectors
  • Market Challenges
    • Limited awareness about the benefits and usage of acute care needleless connectors

Porter's Five Forces: A Strategic Tool for Navigating the Acute Care Needleless Connectors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute Care Needleless Connectors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute Care Needleless Connectors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute Care Needleless Connectors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute Care Needleless Connectors Market

A detailed market share analysis in the Acute Care Needleless Connectors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute Care Needleless Connectors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute Care Needleless Connectors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute Care Needleless Connectors Market

A strategic analysis of the Acute Care Needleless Connectors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute Care Needleless Connectors Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AdvaCare Pharma, Amsino International, Inc., B. Braun Melsungen AG, Baxter International, Inc., Becton Dickinson and Company, Cardinal Health, Inc., ICU Medical, Inc., JCM-MED, MEDEREN, Medline Industries, LP., Merit Medical Systems, Inc., Narang Medical Limited, Nexus Medical, Polymedicur, Romsons Group of Industries, Surgmed Group, Teleflex Incorporated, and Vygon SAS.

Market Segmentation & Coverage

This research report categorizes the Acute Care Needleless Connectors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Mechanism, market is studied across Negative Fluid Displacement, Neutral Fluid Displacement, and Positive Fluid Displacement.
  • Based on End User, market is studied across Clinics & Ambulatory Settings and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing focus on minimizing the risk of infection transmission through needlestick injuries
      • 5.1.1.2. Prevalence of chronic diseases and rise in prescription of intravenous therapy
      • 5.1.1.3. Adoption of acute-care-needleless-connectors owing to ease of use and convenience
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with acute care needleless connectors
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous innovations in materials and performance of acute care needleless connectors
      • 5.1.3.2. Introduction of novel acute care needleless connectors
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness about the benefits and usage of acute care needleless connectors
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acute Care Needleless Connectors Market, by Mechanism

  • 6.1. Introduction
  • 6.2. Negative Fluid Displacement
  • 6.3. Neutral Fluid Displacement
  • 6.4. Positive Fluid Displacement

7. Acute Care Needleless Connectors Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics & Ambulatory Settings
  • 7.3. Hospitals

8. Americas Acute Care Needleless Connectors Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Acute Care Needleless Connectors Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Acute Care Needleless Connectors Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AdvaCare Pharma
  • 3. Amsino International, Inc.
  • 4. B. Braun Melsungen AG
  • 5. Baxter International, Inc.
  • 6. Becton Dickinson and Company
  • 7. Cardinal Health, Inc.
  • 8. ICU Medical, Inc.
  • 9. JCM-MED
  • 10. MEDEREN
  • 11. Medline Industries, LP.
  • 12. Merit Medical Systems, Inc.
  • 13. Narang Medical Limited
  • 14. Nexus Medical
  • 15. Polymedicur
  • 16. Romsons Group of Industries
  • 17. Surgmed Group
  • 18. Teleflex Incorporated
  • 19. Vygon SAS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦